HeathcareA vaccine can be developed "very quickly", says British...

A vaccine can be developed “very quickly”, says British specialist


- Advertisement -

He is the man who conducted the research on the Oxford / AstraZeneca vaccine against the coronavirus. Professor Andrew Pollard, director of the Oxford Vaccine Group, told the BBC on Saturday that a new serum could be developed “very quickly” against the Omicron variant.

It is “extremely unlikely” that this new variant will spread strongly within the vaccinated population, “as we saw last year” with the Delta variant. But if this were the case, “it would be possible to act very quickly”, because “the processes of developing a new vaccine are increasingly well-oiled”. However, he believes that the current vaccines should work against the new strain deemed “worrying” by the WHO, but that this would only be certain in the coming weeks.

Cases in Germany, Belgium …

No case of the Omicron variant has yet been detected in the United Kingdom, one of the countries in Europe most bereaved by the virus with more than 144,500 dead. The government, however, on Thursday announced severe restrictions on passengers from six African countries, including South Africa, where the variant was first detected.

- Advertisement -

In Europe, a case linked to the Omicron variant has so far been discovered in Belgium and another in Germany. About sixty people who tested positive on their return from South Africa are also worrying the Netherlands, but it has not yet been confirmed that they are carrying the new variant. The latter has also been identified in Malawi, Israel on a person from Malawi, Botswana and Hong Kong.

Confident vaccine makers

In a statement, AstraZeneca said it has “developed, in close collaboration with the University of Oxford, a vaccine platform that allows us to respond quickly to new variants that may appear”. The British pharmaceutical company announced that it was “already conducting research in the places where the variant has been identified”.

- Advertisement -

Vaccine makers Pfizer / BioNTech, Moderna and Novavax have also expressed confidence in their ability to combat the Omicron strain.


- Advertisement -
Janice Thomas
Janice Thomas is a content editor at 24 News Recorder. She has 5 years of journalism experience and she he is a graduate of Wittenberg University and holds a master’s degree in journalism from the Medill School of Journalism at Northwestern University.


Please enter your comment!
Please enter your name here

Latest news

France is ready to send hundreds of soldiers to Romania

France is prepared to send hundreds of soldiers to Romania and would be in charge of setting up an...

How much is the dollar worth in Chile: check the exchange rate here today, Saturday, January 29

Lima, January 29, 2022Updated on 01/29/2022 08:34 amThe dollar price in Chile it operates on the rise on...

DolarToday Venezuela Today, Saturday, January 29: How much is the exchange rate trading at?

Lima, January 29, 2022Updated on 01/29/2022 08:22 amThe dollar price in Venezuela, according to DolarToday, it operated this...

Rupture of oil pipeline in Ecuador generates oil spill in the Amazon region

The rupture of an oil pipeline in a sector of the Amazon Ecuadorian affected by a process of soil...

Must read

You might also likeRELATED
Recommended to you